Corcept Therapeutics (CORT) Other Working Capital Changes (2010 - 2026)

Corcept Therapeutics has reported Other Working Capital Changes for 7 years, with the latest figure at -$251000.0 in Q4 2025.

• Quarterly Other Working Capital Changes fell 273.1% year-over-year to -$251000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$829000.0 (down 553.01% YoY) and the FY2025 annual result came in at -$829000.0, down 553.01% from the prior year.
• Other Working Capital Changes retreated to -$251000.0 in Q4 2025 per CORT's latest filing, from -$247000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $13.5 million in Q1 2025 and troughed at -$9.6 million in Q2 2025.
• A 5-year average of $1.7 million and a median of $2.4 million in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 297.22% in 2024, then tumbled 693.1% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$520000.0 in 2021, then dropped by 8.46% to -$564000.0 in 2022, then surged by 86.88% to -$74000.0 in 2023, then surged by 295.95% to $145000.0 in 2024, then sank by 273.1% to -$251000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$251000.0, -$247000.0, and -$230000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.